ARCHIVES

FDA Warns of Lymphoma Risk Associated With Breast Implants

This article is from The Cancer Letter archive.

Vol. 37 No. 04 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control

May 11, 1984

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?

June 30, 2000

House Science Committee Chairman Questions NIH Budget Increases.

February 2, 2001

DCT Board Agrees To Use Of Program Announcement For New Surgery Grants

March 13, 1981

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002